A KRAS-directed ctDNA assay solidly outperformed standard next-generation sequencing in detecting residual pancreatic cancer. Could it eventually help guide KRAS-targeted therapies?
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/better-test-finding-residual-pancreatic-cancer-2026a1000mjq?src=rss
Author :
Publish date : 2026-07-02 12:39:00
Copyright for syndicated content belongs to the linked Source.